UBE2Q2 Antibody (monoclonal) (M04)
Mouse monoclonal antibody raised against a partial recombinant UBE2Q2.
|Application ||WB, IF, E|
|Calculated MW||42818 Da|
|Other Names||Ubiquitin-conjugating enzyme E2 Q2, Ubiquitin carrier protein Q2, Ubiquitin-protein ligase Q2, UBE2Q2|
|Target/Specificity||UBE2Q2 (NP_775740, 1 a.a. ~ 110 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||UBE2Q2 Antibody (monoclonal) (M04) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
New loci associated with kidney function and chronic kidney disease. K?ttgen A, et al. Nat Genet, 2010 May. PMID 20383146.Overexpression of the novel human gene, UBE2Q2, in breast cancer. Nikseresht M, et al. Cancer Genet Cytogenet, 2010 Mar. PMID 20193842.Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer. Maeda H, et al. Mol Cancer Res, 2009 Sep. PMID 19723876.Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents. Banerjee S, et al. Oncogene, 2007 Oct 4. PMID 17471241.Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Seghatoleslam A, et al. Biochem Biophys Res Commun, 2006 Jan 6. PMID 16300736.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.